The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost the effectiveness of radiotherapy ...

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

As the medical community grapples with a significant rise in HPV-related head and neck cancers among younger, non-smoking demographics, a local expert is sounding the alarm on a secondary, silent ...

When are protons are typically preferred in treating head and neck cancers? While there are general principles, the decision to treat head and neck cancers with proton radiation at Fred Hutch Cancer ...

In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...

A small prospective study from Taiwan showed that olfactory function begins to deteriorate at a radiation therapy dose of 22 Gy in patients with head and neck cancer. Only 17% of patients developed ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

A multi-disciplinary task force convened by the American Society for Radiation Oncology has issued new guidelines for radiation therapy for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) ...

SHREVEPORT, La. - A new landmark study published in The Lancet is changing how doctors treat certain head and neck cancers. One of the researchers involved, radiation oncologist Dr. Sanford Katz, ...

Jefferson Health oncologist Jennifer Johnson had exhausted all the standard treatment options for her 49-year-old patient with esophageal cancer, who was likely to die within months. Surgery, ...